Higher Risk of Abdominal Obesity, Elevated Low-Density Lipoprotein Cholesterol, and Hypertriglyceridemia, but not of Hypertension, in People Living With Human Immunodeficiency Virus (HIV): Results From the Copenhagen Comorbidity in HIV Infection Study
- 17 February 2018
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 67 (4) , 579-586
Abstract
People living with human immunodeficiency virus (PLWH) are characterized by excess risk of cardiovascular diseases (CVD) and CVD risk factors compared to uninfected individuals. We investigated the association between HIV infection and abdominal obesity, elevated low-density lipoprotein cholesterol (LDL-C), hypertriglyceridemia, and hypertension in a large cohort of predominantly well-treated PLWH and matched controls. 1099 PLWH from the Copenhagen Co-morbidity in HIV Infection Study and 12 161 age- and sex-matched uninfected controls from the Copenhagen General Population Study were included and underwent blood pressure, waist, hip, weight, and height measurements and nonfasting blood samples. We assessed whether HIV was independently associated with abdominal obesity, elevated LDL-C, hypertriglyceridemia, and hypertension using logistic regression models adjusted for known risk factors. HIV infection was associated with higher risk of abdominal obesity (adjusted odds ratio [aOR], 1.92 [1.60–2.30]) for a given body mass index, elevated LDL-C (aOR, 1.32 [1.09–1.59]), hypertriglyceridemia (aOR, 1.76 [1.49–2.08]), and lower risk of hypertension (aOR, 0.63 [0.54–0.74]). The excess odds of abdominal obesity in PLWH was stronger with older age (p interaction, 0.001). Abdominal obesity was associated with elevated LDL-C (aOR, 1.44 [1.23–1.69]), hypertension (aOR, 1.32 [1.16–1.49]), and hypertriglyceridemia (aOR, 2.12 [1.86–2.41]). Abdominal obesity was associated with proaterogenic metabolic factors including elevated LDL-C, hypertension, and hypertriglyceridemia and remains a distinct HIV-related phenotype, particularly among older PLWH. Effective interventions to reduce the apparent detrimental impact on cardiovascular risk from this phenotype are needed.Keywords
This publication has 36 references indexed in Scilit:
- Regional fat deposition and cardiovascular risk in HIV infection: the FRAM studyAIDS Care, 2011
- Life expectancy of recently diagnosed asymptomatic HIV-infected patients approaches that of uninfected individualsAIDS, 2010
- Harmonizing the Metabolic SyndromeCirculation, 2009
- Does Greater Adiposity Increase Blood Pressure and Hypertension Risk?Hypertension, 2009
- Hypertension in an urban HIV-positive population compared with the general population: influence of combination antiretroviral therapyJournal Of Hypertension, 2008
- Lipodystrophy in HIV 1-infected patients: lessons for obesity researchInternational Journal of Obesity, 2007
- Nonfasting Triglycerides and Risk of Myocardial Infarction, Ischemic Heart Disease, and Death in Men and WomenJAMA, 2007
- Prevalence of Hypertension in HIV-Positive Patients on Highly Active Retroviral Therapy (HAART) Compared with HAART-Na ve and HIV-Negative Controls: Results from a Norwegian Study of 721 PatientsEuropean Journal of Clinical Microbiology & Infectious Diseases, 2003
- Risk factors for the HIV‐associated lipodystrophy syndrome in a closed cohort of patients after 3 years of antiretroviral treatmentHIV Medicine, 2002
- Metabolic Abnormalities and Cardiovascular Disease Risk Factors in Adults with Human Immunodeficiency Virus Infection and LipodystrophyClinical Infectious Diseases, 2001